Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
HOLOGIC INC
SIC 3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
HOLOGIC INC
SIC 3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
HOLOGIC INC
SIC 3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Support
about
terms
HOLOGIC INC
CIK:
0000859737
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.25.4
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Revenues:
Revenues
$ 1,047.8
$ 1,021.8
Costs of revenues:
Amortization of acquired intangible assets
41.0
46.0
Gross profit
586.4
580.5
Operating expenses:
Research and development
60.5
60.3
Selling and marketing
154.9
166.1
General and administrative
127.8
115.7
Amortization of acquired intangible assets
2.3
4.7
Restructuring charges
3.9
3.9
Operating expenses
349.4
350.7
Income from operations
237.0
229.8
Interest income
19.7
24.2
Interest expense
(27.6)
(30.5)
Other income
0.6
24.0
Income before income taxes
229.7
247.5
Provision for income taxes
50.6
46.5
Net income
$ 179.1
$ 201.0
Net income per common share:
Basic (in usd per share)
$ 0.80
$ 0.87
Diluted (in usd per share)
$ 0.79
$ 0.87
Weighted average number of shares outstanding:
Basic (in shares)
224,405
230,284
Diluted (in shares)
225,879
232,107
Product
Revenues:
Revenues
$ 831.4
$ 817.9
Costs of revenues:
Cost of revenues
321.9
301.1
Service
Revenues:
Revenues
216.4
203.9
Costs of revenues:
Cost of revenues
$ 98.5
$ 94.2
v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Mar. 29, 2025
Dec. 28, 2024
OPERATING ACTIVITIES
Net income
$ 179.1
$ 187.2
$ (17.4)
$ 201.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
26.3
23.3
Amortization of acquired intangible assets
43.3
50.7
Stock-based compensation expense
26.9
30.1
Deferred income taxes
(1.1)
(19.5)
Other adjustments and non-cash items
6.6
(19.1)
Changes in operating assets and liabilities:
Accounts receivable
18.0
(41.7)
Inventories
(8.6)
(36.1)
Prepaid income taxes
3.2
29.2
Prepaid expenses and other assets
(25.1)
13.2
Accounts payable
7.8
36.2
Accrued expenses and other liabilities
(17.3)
(54.6)
Deferred revenue
(29.2)
(23.4)
Net cash provided by operating activities
229.9
189.3
INVESTING ACTIVITIES
Capital expenditures
(14.7)
(16.8)
Increase in equipment under customer usage agreements
(20.4)
(14.8)
Strategic investments
24.0
6.0
Purchase of intellectual property
0.0
(15.4)
Maturities of available-for-sale securities
48.0
32.0
Other activity
(1.0)
(1.0)
Net cash used in investing activities
(12.1)
(22.0)
FINANCING ACTIVITIES
Repayment of long-term debt
0.0
(9.4)
Repurchases of common stock
0.0
(517.3)
Proceeds under employee stock plans
8.3
12.2
Payment of minimum tax withholdings on net share settlements of equity awards
(18.1)
(21.7)
Payments under finance lease obligations
(0.9)
(0.8)
Net cash used in financing activities
(10.7)
(537.0)
Effect of exchange rate changes on cash and cash equivalents
1.4
(8.4)
Net increase (decrease) in cash and cash equivalents
208.5
(378.1)
Cash and cash equivalents, beginning of period
1,959.5
$ 1,782.1
2,160.2
Cash and cash equivalents, end of period
$ 2,168.0
$ 1,959.5
$ 1,782.1
v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 27, 2025
Sep. 27, 2025
Current assets:
Cash and cash equivalents
$ 2,168.0
$ 1,959.5
Short-term investments
196.7
243.2
Accounts receivable, less reserves
584.2
600.8
Inventory
688.5
679.4
Prepaid expenses and other current assets
176.0
152.0
Prepaid income taxes
30.0
33.2
Total current assets
3,843.4
3,668.1
Property, plant and equipment, net
568.3
559.6
Intangible assets, net
547.3
589.1
Goodwill
3,645.2
3,640.6
Other assets
576.5
557.5
Total assets
9,180.7
9,014.9
Current liabilities:
Current portion of long-term debt
5.8
2.9
Accounts payable
201.1
193.4
Accrued expenses
570.0
577.7
Deferred revenue
170.9
199.7
Finance lease obligations
3.5
3.5
Total current liabilities
951.3
977.2
Long-term debt, net of current portion
2,502.9
2,505.0
Finance lease obligations, net of current portion
8.1
9.0
Deferred income tax liabilities
41.9
43.4
Deferred revenue, net of current portion
12.4
12.4
Other long-term liabilities
419.0
420.0
Stockholders’ equity:
Preferred stock, $0.01 par value – 1,623 shares authorized; 0 shares issued
0.0
0.0
Common stock, $0.01 par value – 750,000 shares authorized; 302,940 and 302,438 shares issued, respectively
3.0
3.0
Additional paid-in-capital
6,357.5
6,345.4
Retained earnings
3,590.6
3,411.5
Treasury stock, at cost – 79,874 and 79,874 shares, respectively
(4,611.2)
(4,611.2)
Accumulated other comprehensive loss
(94.8)
(100.8)
Total stockholders’ equity
5,245.1
5,047.9
Total liabilities and stockholders’ equity
$ 9,180.7
$ 9,014.9